Top Markets
Coin of the day
DataMEDS AI, Inc. DataMEDS AI, Inc.

DataMEDS AI, Inc.

MEDS
Rank in Stocks #35426
DataMEDS AI is a Health IT company focused on the vertical integration of... DataMEDS AI is a Health IT company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units. The company incorporates its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to optimize the prescription medicines reimbursement and dispensing journey.
Share Price
$1.50
Last synced: 2026-08-14
Market Cap
$3.92M
Change (1 day)
0.34%
Change (1 year)
-95.19%
Country
US
Trade DataMEDS AI, Inc. (MEDS)

Category

Revenue for DataMEDS AI, Inc. (MEDS)
Revenue in Mar 2026 TTM: $14.03M
According to DataMEDS AI, Inc. latest financial reports the company's current revenue (TTM) is $14.03M. In 2023 the company made a revenue of $8.27M a decrease compared to the revenue in the year 2022 that was $11.45M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for DataMEDS AI, Inc. from 2006 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $14.03M 10,170.54%
2024 $136.64K -98.35%
2023 $8.27M -27.74%
2022 $11.45M 15.76%
2021 $9.89M -42.24%
2020 $17.12M 130.26%
2019 $7.44M 94.07%
2018 $3.83M 30.72%
2017 $2.93M 18.11%
2016 $2.48M -50.29%
2015 $4.99M 233.65%
2014 $1.50M 56.53%
2013 $955.88K 18.59%
2012 $806.05K 0.00%
2008 0.00 0.00%
2007 0.00 0.00%
2006 0.00 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$410.98B 2,928,385.01%
US
- -
US
$254.25B 1,811,559.99%
US
- -
US
$3.67B 26,081.01%
AU